Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial

被引：0
|
作者：
Jin-ping Zheng
Yun Ling
Liang-shuang Jiang
Piroon Mootsikapun
Hong-zhou Lu
Methee Chayakulkeeree
Li-xiu Zhang
Pureepat Arttawejkul
Feng-yu Hu
Thi Ngoc Lan Truong
Roxan A. Perez
Xing Gu
Hui-min Sun
Jian-jie Jiang
Ren-jie Liu
Zhen Ding
Yang-qing Zhan
Zi-feng Yang
Wei-jie Guan
Nan-shan Zhong
机构：
[1] Guangzhou Institute for Respiratory Health,State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease
[2] The First Affiliated Hospital of Guangzhou Medical University,undefined
[3] Shanghai Public Health Clinical Center,undefined
[4] Public Health Clinical Center of Chengdu,undefined
[5] Srinagarind Hospital,undefined
[6] The Third People’s Hospital of Shenzhen,undefined
[7] Siriraj Hospital,undefined
[8] The Affiliated Hospital of Changchun University of TCM,undefined
[9] Burapha University Hospital,undefined
[10] Guangzhou Eighth People’s Hospital,undefined
[11] Guangzhou Medical University,undefined
[12] Traditional Medicine Institute of Ho Chi Minh City,undefined
[13] Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium,undefined
[14] Xi’an Chest Hospital,undefined
[15] Tangshan Hospital of Traditional Chinese Medicine,undefined
[16] Kunming Third People’s Hospital,undefined
[17] First People’s Hospital of Zhengzhou City,undefined
[18] Hefei Binhu Hospital,undefined
来源：
Virology Journal | / 20卷
关键词：
Coronavirus disease 2019; Omicron; Lianhuaqingwen Capsule; Symptom resolution; Inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Randomized, double-blind, placebo-controlled trial of oral albuterol in infants with mild-to-moderate acute viral bronchiolitis
    Patel, H
    Gouin, S
    Platt, RW
    JOURNAL OF PEDIATRICS, 2003, 142 (05): : 509 - 514
  • [22] Efficacy and Safety of Guilingji Capsules (龟龄集胶囊) for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial
    Nan-yang Liu
    Hui Pei
    Mei-xia Liu
    Long-tao Liu
    Chang-geng Fu
    Hao Li
    Ke-ji Chen
    Chinese Journal of Integrative Medicine, 2020, 26 : 577 - 582
  • [23] Efficacy and Safety of Guilingji Capsules(龟龄集胶囊) for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial
    LIU Nan-yang
    PEI Hui
    LIU Mei-xia
    LIU Long-tao
    FU Chang-geng
    LI Hao
    CHEN Ke-ji
    Chinese Journal of Integrative Medicine , 2020, (08) : 577 - 582
  • [24] Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
    Gold, Linda Stein
    Papp, Kim
    Pariser, David
    Green, Lawrence
    Bhatia, Neal
    Sofen, Howard
    Albrecht, Lorne
    Gooderham, Melinda
    Chen, Mindy
    Paris, Maria
    Wang, Yao
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 77 - 85
  • [25] Efficacy and Safety of Guilingji Capsules(龟龄集胶囊) for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial
    LIU Nan-yang
    PEI Hui
    LIU Mei-xia
    LIU Long-tao
    FU Chang-geng
    LI Hao
    CHEN Ke-ji
    Chinese Journal of Integrative Medicine, 2020, 26 (08) : 577 - 582
  • [26] A double-blind, randomized investigation of the effects of testosterone or placebo in male patients with mild-to-moderate Alzheimer's disease
    Miller, B
    DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000, 2002, : 253 - 262
  • [27] CAPTOPRIL COMPARED TO ATENOLOL IN MILD TO MODERATE HYPERTENSION IN A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
    HAVINGA, TK
    TENBERGE, BS
    MAY, JF
    SCHUURMAN, FH
    VANDERVEUR, E
    WESSELING, H
    NETHERLANDS JOURNAL OF MEDICINE, 1991, 38 (1-2): : 13 - 17
  • [28] A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
    Kim, Jin Yong
    Sandulescu, Oana
    Preotescu, Liliana-Lucia
    Rivera-Martinez, Norma E.
    Dobryanska, Marta
    Birlutiu, Victoria
    Miftode, Egidia G.
    Gaibu, Natalia
    Caliman-Sturdza, Olga
    Florescu, Simin-Aysel
    Shi, Hye Jin
    Streinu-Cercel, Anca
    Streinu-Cercel, Adrian
    Lee, Sang Joon
    Kim, Sung Hyun
    Chang, Ilsung
    Bae, Yun Ju
    Suh, Jee Hye
    Chung, Da Rae
    Kim, Sun Jung
    Kim, Mi Rim
    Lee, Seul Gi
    Park, Gahee
    Eom, Joong Sik
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (08):
  • [29] Efficacy and Safety of Lianhuaqingwen Capsules, a repurposed Chinese Herb, in Patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial (vol 85, 153242, 2021)
    Hu, Ke
    Guan, Wei-jie
    Bi, Ying
    Zhang, Wei
    Li, Lanjuan
    Zhang, Boli
    Liu, Qingquan
    Song, Yuanlin
    Li, Xingwang
    Duan, Zhongping
    Zheng, Qingshan
    Yang, Zifeng
    Liang, Jingyi
    Han, Mingfeng
    Ruan, Lianguo
    Wu, Chaomin
    Zhang, Yunting
    Jia, Zhen-hua
    Zhong, Nan-shan
    PHYTOMEDICINE, 2021, 93
  • [30] Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild-to-moderate atopic dermatitis: A randomized, double-blind, vehicle-controlled trial
    Kim, Min Seo
    Kim, Hyeon Jin
    Kang, So Min
    Heo, Young Mok
    Kang, Jiseung
    Ryu, Tae Kyeong
    Kim, Hyun Jeong
    Choi, Young-Bong
    Kim, Sol
    Nho, Youn Hwa
    Kang, Seunghyun
    Smith, Lee
    Koyanagi, Ai
    Papadopoulos, Nikolaos G.
    Jo, Hyungwoo
    Lee, Dong-Geol
    Shin, Jung U.
    Yon, Dong Keon
    ALLERGY, 2024, 79 (06) : 1612 - 1616
12345